BackNeumora Therapeutics Overview

Neumora Therapeutics Income Tax

Neumora Therapeutics's income tax is $30K.

Get informed when a big investor buys or sells

+ Follow

Quarterly Income Tax

$0
100.00% YoY

As of Jun 2026

Annual Income Tax (TTM)

$30000.00
83.61% YoY

Trailing 12 months ending Jun 2026

Average Income Tax (Comparison Companies)

Loading

Income Tax History

Loading

Income Tax Comparison

Loading

Annual Income Tax Growth Rate (%)

Loading...

Annual Income Tax Growth (Absolute)

Loading...

Neumora Therapeutics (NMRA) FAQ

As of the most recent data (June 2026), NMRA shows a income tax of $30K. That compares with $180K in the prior-year period — down 83.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NMRA's income tax is now $30K (was $180K) — a 83.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Neumora Therapeutics is outperforming or lagging.

Tracking NMRA's income tax over time shows whether Neumora Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $30K That compares with $180K in the prior-year period — down 83.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this income tax page, Stockcircle has Neumora Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect income tax (currently $30K) with ownership activity and broader fundamentals.